Gillette India Limited (GILLETTE)

Fast Moving Consumer Goods · Personal Products · NSE · Updated 5 July 2026
₹7,610.5 ↓ 28.8% (1Y)

🎯 Key Takeaways

  • Gillette India is in a mature cash cow phase with declining revenue trends, as reflected in its -28.8% one-year return and elevated P/E of 41.
  • ⚠️ Sustained revenue decline without a visible recovery strategy raises concerns about long-term profitability.
Market Cap
₹25,438
P/E Ratio
41.0
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Gillette India is in a mature cash cow phase with declining revenue trends, as reflected in its -28.8% one-year return and elevated P/E of 41.0. The company continues to return capital via dividends while navigating leadership transitions and regulatory compliance requirements. Management is focused on maintaining shareholder distributions despite flat growth, signaling a prioritization of cash return over reinvestment.

📰 What's Happening

In Q1 FY26, Gillette India proposed a final dividend of ₹60 per share for FY25-26, pending shareholder approval at the upcoming AGM, continuing its historical pattern of consistent payouts. The company also appointed Mr. Gopalakrishnan Kalianna as Sales Head effective August 1, 2026, following the resignation of Ms. Rohini Venkateswaran, who transitioned to a regional role in Korea. Additionally, a trading window closure was announced for designated persons and relatives from July 1, 2026, until 48 hours post-results, in compliance with SEBI insider trading norms. These events underscore operational continuity and governance discipline amid financial headwinds.

Source: Stock Announcements

🔮 Management Outlook & What's Next

Management has not provided forward-looking guidance on revenue recovery or margin improvement in the recent filings. The only forward-looking elements are procedural, including dividend eligibility requirements and leadership transition timelines. Absence of strategic commentary suggests limited confidence in near-term growth catalysts, with focus instead on compliance and governance continuity.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Personal Products

Company MCap (₹ Cr) P/E ROCE ROE D/E
Godrej Consumer Products Limited 1.06 L Cr -234.6
Dabur India Limited 82,955 46.1
Colgate Palmolive (India) Limited 58,749 44.3
Procter & Gamble Hygiene and Health Care Limited 31,506 36.7
Gillette India Limited 25,438 41.0
Emami Limited 18,684 23.6
Cupid Limited 16,184 668.7
Honasa Consumer Limited 11,518 145.1
Bajaj Consumer Care Limited 7,020 58.5
JHS Svendgaard Laboratories Limited 80 -5.8

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Sustained revenue decline without a visible recovery strategy raises concerns about long-term profitability. 2. Leadership transition in sales may disrupt commercial momentum despite management’s assurance of continuity. 3. High P/E multiple (41.0) is difficult to justify amid negative returns and flat growth, increasing valuation sensitivity. 4. Overreliance on dividend payouts without reinvestment could pressure shares if earnings remain stagnant.

📋 Recent Filings

🧠 Analyst's Read

Gillette India appears to be operating in a defensive, cash-generating mode with limited growth visibility. Investors should monitor future earnings calls and investor presentations for any indication of strategic shifts, but current disclosures suggest a focus on maintaining dividends rather than driving transformation.

Based on filing content and financial data. Not a recommendation.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-05.

📡 Get AI alerts when GILLETTE files new disclosures

Track GILLETTE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GILLETTE — Free

Free account · No credit card · 2 AI queries/day